Exact Imaging, a Canadian firm, won the European CE Mark to introduce its ExactVu prostate imaging and biopsy guidance system to the European market. It is a micro-ultrasound system that provides a resolution down to 70 microns, allowing a physician to visualize the prostate in real time and in high detail. The ExactVu relies on a 29 MHz transducer that is placed directly against the prostate to identify suspect lesion that should be sampled in a biopsy and to help guide the biopsy to the target location.
Besides the high resolution probe that’s inserted through the rear, the system comes with two conventional trans-abdominal probes for kidney, bladder, and prostate imaging. And it includes an integrated disposable biopsy device for a complete package that can be quickly introduced into the clinic.
The unit itself has an adjustable control panel and a touchscreen interface with a bunch of presets one can tune.
“There is significant built-up demand for acquiring the ExactVu instrument and this approval will allow us to be able to commercialize our platform in Europe. said Randy AuCoin, Exact Imaging’s President and CEO, in a statement. “With the ExactVu platform, urologists will have a new level of real-time resolution to facilitate actually targeting their prostate biopsies at suspicious regions. The goal is to provide the best tools to help the urologist make the most informed decisions and ultimately, to improve patient outcomes.”
Here’s a talk by Dr. Sangeet Ghaiof the University of Toronto discussing the clinical implications of micro-ultrasound:
Link: Exact Imaging…